Order Article Reprints

Blinova E, Enikeev D, Roshchin D, Samyshina E, Deryabina O, Tertychnyy A, Blinov D, Kogan E, Dudina M, Barakat H, et al. Relapse-Free Survival and PD-L1 Expression in First High- and Low-Grade Relapsed Luminal, Basal and Double-Negative P53-Mutant Non-Muscular Invasive Bladder Cancer Depending on Previous Chemo- and Immunotherapy. Cancers. 2020; 12(5):1316. https://doi.org/10.3390/cancers12051316

Blinova, Ekaterina, Dmitry Enikeev, Dmitry Roshchin, Elena Samyshina, Olga Deryabina, Aleksander Tertychnyy, Dmitry Blinov, Evgenia Kogan, Marina Dudina, Haydar Barakat, and et al. 2020. "Relapse-Free Survival and PD-L1 Expression in First High- and Low-Grade Relapsed Luminal, Basal and Double-Negative P53-Mutant Non-Muscular Invasive Bladder Cancer Depending on Previous Chemo- and Immunotherapy" Cancers 12, no. 5: 1316. https://doi.org/10.3390/cancers12051316

Blinova, E., Enikeev, D., Roshchin, D., Samyshina, E., Deryabina, O., Tertychnyy, A., Blinov, D., Kogan, E., Dudina, M., Barakat, H., Merinov, D., Kachmazov, A., Serebrianyi, S., Potoldykova, N., & Perepechin, D. (2020). Relapse-Free Survival and PD-L1 Expression in First High- and Low-Grade Relapsed Luminal, Basal and Double-Negative P53-Mutant Non-Muscular Invasive Bladder Cancer Depending on Previous Chemo- and Immunotherapy. Cancers, 12(5), 1316. https://doi.org/10.3390/cancers12051316